10-Q

Company

Aclaris Therapeutics, Inc.

Filed

August 7, 2025

Period of Report

June 30, 2025

Accession Number

0001558370-25-010789

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →